mhurhangee/ep-ind-claims huggingface dataset:
A method of operating a wireless device, comprising: receiving a broadcast signal from an access point, the broadcast signal including transmission power control information; measuring a received pilot power level; determining a transmission power to be used for an access request signal based on the received transmission power control information and the measured received pilot power level; and characterized by determining if the broadcast signal includes inaccurate transmission power control information and conveying a recommended change to the transmission power control information when it is determined that transmission power control information included in the broadcast signal includes inaccurate transmission power control information. receiving a broadcast signal from an access point, the broadcast signal including transmission power control information; measuring a received pilot power level; determining a transmission power to be used for an access request signal based on the received transmission power control information and the measured received pilot power level; and characterized by determining if the broadcast signal includes inaccurate transmission power control information and conveying a recommended change to the transmission power control information when it is determined that transmission power control information included in the broadcast signal includes inaccurate transmission power control information.
Use of compacted spheroidal pellets in precision farming, the pellets comprising a calcium source and optionally a magnesium source, wherein said pellets have: - an average size lower than 10 mm, measured by sieve analysis, and - a granule density equal to or higher than 1.60 g/cm 3, preferably equal to or higher than 1.70 g/cm 3, measured by mercury picnometry, characterized by said calcium source comprising at least CaO, said magnesium source comprising at least MgO, wherein the pellets comprise at least 60 wt%, preferably 70 wt% of said CaO and/or said MgO, based on the total weight of the pellets. - an average size lower than 10 mm, measured by sieve analysis, and - a granule density equal to or higher than 1.60 g/cm 3, preferably equal to or higher than 1.70 g/cm 3, measured by mercury picnometry,
A system for providing radiotherapy treatment to a target volume of a patient, the system comprising: a radiation treatment machine including a multileaf collimator having multiple pairs of opposed linearly displaceable leaves; and a computer that executes a radiotherapy treatment control program that is configured to control the radiation treatment machine so as to: configure the multileaf collimator in a first orientation so as to form an actual aperture having a first orientation, deliver radiation to the target volume through the actual aperture while in the first orientation with a single pass along an arcuate path centered on the target volume, configure the multileaf collimator in a second orientation so as to place the actual aperture in a second orientation that is different from the first orientation, and deliver radiation to the target volume through the actual aperture while in the second orientation with a single pass back along the arcuate path such that a relatively large cumulative dose of radiation is delivered to the target volume through a virtual aperture created by an area of overlap between the first and second actual aperture orientations. a radiation treatment machine including a multileaf collimator having multiple pairs of opposed linearly displaceable leaves; and a computer that executes a radiotherapy treatment control program that is configured to control the radiation treatment machine so as to: configure the multileaf collimator in a first orientation so as to form an actual aperture having a first orientation, deliver radiation to the target volume through the actual aperture while in the first orientation with a single pass along an arcuate path centered on the target volume, configure the multileaf collimator in a second orientation so as to place the actual aperture in a second orientation that is different from the first orientation, and deliver radiation to the target volume through the actual aperture while in the second orientation with a single pass back along the arcuate path such that a relatively large cumulative dose of radiation is delivered to the target volume through a virtual aperture created by an area of overlap between the first and second actual aperture orientations. configure the multileaf collimator in a first orientation so as to form an actual aperture having a first orientation, deliver radiation to the target volume through the actual aperture while in the first orientation with a single pass along an arcuate path centered on the target volume, configure the multileaf collimator in a second orientation so as to place the actual aperture in a second orientation that is different from the first orientation, and deliver radiation to the target volume through the actual aperture while in the second orientation with a single pass back along the arcuate path such that a relatively large cumulative dose of radiation is delivered to the target volume through a virtual aperture created by an area of overlap between the first and second actual aperture orientations.
Covering device for covering a tubing system that can be connected to a patient, comprising a sheet with a liquid sensor, characterized in that the sheet has a first bending edge, and the liquid sensor and the first bending edge are arranged on the sheet in such a way that, when the sheet is folded along the bending edge, the liquid sensor is arranged in a gusseted pocket formed by the folding, and in that the sheet has a second bending edge, which runs largely parallel to the first bending edge and is formed in the opposite direction from the first bending edge such that, when the sheet is folded along the first and the second bending edges (4, 4'), a zigzag fold with two gusseted pockets is formed and in that the underside of the sheet is impermeable to liquid. in that the sheet has a second bending edge, which runs largely parallel to the first bending edge and is formed in the opposite direction from the first bending edge such that, when the sheet is folded along the first and the second bending edges (4, 4'), a zigzag fold with two gusseted pockets is formed and in that the underside of the sheet is impermeable to liquid.
Silica particles characterized by: (i) a d50 median particle size in a range from about 8 to 20 μm; (ii) a sphericity factor (S 80) of greater than or equal to 0.9; (iii) a BET surface area in a range from 0.1 to 6 m 2 /g: (iv) a total mercury intrusion pore volume in a range from 0.35 to 0.7 cc/g; and (v) a loss on ignition in a range from 3 to 7 wt. % (i) a d50 median particle size in a range from about 8 to 20 μm; (ii) a sphericity factor (S 80) of greater than or equal to 0.9; (iii) a BET surface area in a range from 0.1 to 6 m 2 /g: (iv) a total mercury intrusion pore volume in a range from 0.35 to 0.7 cc/g; and (v) a loss on ignition in a range from 3 to 7 wt. %
A system comprising a parameter generation system to determine parameters of at least a first phase of an injection procedure based at least in part upon a type of the injection procedure, wherein at least a first portion V 1 of a volume in millilitres of a pharmaceutical to be injected is determined by the parameter generation system, and wherein the system is characterized in that the parameter generator system determines the amount of the pharmaceutical that is to be delivered to a patient at least partly on the basis of the concentration of an agent in the pharmaceutical and at least partly on the basis of a function X(weight) which is the weight factor that depends on and varies with weight of the patient and the volume is determined by multiplying weight of the patient by a weight factor and dividing by the concentration of the agent in the pharmaceutical using the formula: V 1 = weight * weight factor * 1000 / concentration, wherein the weight is in kilograms, the weight factor in grams of the agent per kilogram and the concentration in milligrams of agent per millilitre.
Device for apparatus power supply - having at least one equipment module (2a; 2b, 2c) with an input connection for a supply cable and with an output connection (4a; 4b, 4c) for an equipment cable with an enclosing cable screen; - having a connection element which can be associated with the equipment module for the entry and fixing of the equipment cable, and - having a form-fit and/or force-fit arrangement at least of one of the connection elements (7a, 7b, 7c) on the equipment module, - wherein by means of the connection element the cable shield can be connected to a zero conductor, - having at least one supply module upstream of the equipment module with an input connection for the supply cable; - having an electrically conductive connection in the sense of a power bus between an output connection of the supply module and the input connection at least of the equipment module (2a; 2b, 2c). - having at least one equipment module (2a; 2b, 2c) with an input connection for a supply cable and with an output connection (4a; 4b, 4c) for an equipment cable with an enclosing cable screen; - having a connection element which can be associated with the equipment module for the entry and fixing of the equipment cable, and - having a form-fit and/or force-fit arrangement at least of one of the connection elements (7a, 7b, 7c) on the equipment module, - wherein by means of the connection element the cable shield can be connected to a zero conductor, - having at least one supply module upstream of the equipment module with an input connection for the supply cable; - having an electrically conductive connection in the sense of a power bus between an output connection of the supply module and the input connection at least of the equipment module (2a; 2b, 2c).
Weapon clearance appliance for clearance of weapons, such as underwater mines or munitions which have been sunk in waterways, under water by blasting the weapon, wherein - a holding apparatus (22, 24) for affixing the weapon clearance appliance to the weapon is provided and - the weapon clearance appliance is configured to be connected to means for detachable connection to an unmanned underwater vehicle, wherein - the means (14, 34, 36) for detachable connection and the holding apparatus (22, 24) are embodied in such a way that, in order to affix the weapon clearance appliance (10, 10') to the weapon when the holding apparatus (22, 24) is activated, the means (14, 34, 36) for detachable connection are actuated at the same time such that a mechanical connection of the weapon clearance appliance (10, 10') to the unmanned underwater vehicle is released. - a holding apparatus (22, 24) for affixing the weapon clearance appliance to the weapon is provided and - the weapon clearance appliance is configured to be connected to means for detachable connection to an unmanned underwater vehicle, wherein - the means (14, 34, 36) for detachable connection and the holding apparatus (22, 24) are embodied in such a way that, in order to affix the weapon clearance appliance (10, 10') to the weapon when the holding apparatus (22, 24) is activated, the means (14, 34, 36) for detachable connection are actuated at the same time such that a mechanical connection of the weapon clearance appliance (10, 10') to the unmanned underwater vehicle is released.
A method for identifying a compound that modulates the interaction of caspase-8 with c-FLIP in a cell, comprising the steps of a1) contacting at least one of caspase-8, a c-FLIP binding fragment of caspase-8, a cell expressing caspase-8, and/or a cell expressing a c-FLIP binding fragment thereof with at least one compound that potentially modulates the interaction of caspase-8 with c-FLIP in a cell, or a2) contacting at least one of c-FLIP, a caspase-8 binding fragment of c-FLIP, a cell expressing c-FLIP, and/or a cell expressing a caspase-8 binding fragment thereof with at least one compound that potentially modulates the interaction of c-FLIP with caspase-8 in a cell, or a3) contacting at least one of a complex of caspase-8 with c-FLIP, a complex of at least one binding fragment of caspase-8 or c-FLIP with c-FLIP or caspase-8, respectively, and/or a cell expressing at least one of a complex of caspase-8 with c-FLIP, a complex of at least one binding fragment of caspase-8 or c-FLIP, with c-FLIP or caspase-8, respectively, with at least one compound that potentially modulates the interaction of said fragment(s) in a cell, and b) identifying a modulation of the binding of c-FLIP or said fragment to caspase-8 or the binding of caspase-8 or said fragment to c-FLIP in the presence of said at least one compound, wherein said modulation is selected from an increase of said binding, a stabilization of said binding, and an increase of caspase-8 activity in said cell, in particular Caspase-8 activity in the heterodimer Caspase-8/c-FLIP L. a1) contacting at least one of caspase-8, a c-FLIP binding fragment of caspase-8, a cell expressing caspase-8, and/or a cell expressing a c-FLIP binding fragment thereof with at least one compound that potentially modulates the interaction of caspase-8 with c-FLIP in a cell, or a2) contacting at least one of c-FLIP, a caspase-8 binding fragment of c-FLIP, a cell expressing c-FLIP, and/or a cell expressing a caspase-8 binding fragment thereof with at least one compound that potentially modulates the interaction of c-FLIP with caspase-8 in a cell, or a3) contacting at least one of a complex of caspase-8 with c-FLIP, a complex of at least one binding fragment of caspase-8 or c-FLIP with c-FLIP or caspase-8, respectively, and/or a cell expressing at least one of a complex of caspase-8 with c-FLIP, a complex of at least one binding fragment of caspase-8 or c-FLIP, with c-FLIP or caspase-8, respectively, with at least one compound that potentially modulates the interaction of said fragment(s) in a cell, and b) identifying a modulation of the binding of c-FLIP or said fragment to caspase-8 or the binding of caspase-8 or said fragment to c-FLIP in the presence of said at least one compound, wherein said modulation is selected from an increase of said binding, a stabilization of said binding, and an increase of caspase-8 activity in said cell, in particular Caspase-8 activity in the heterodimer Caspase-8/c-FLIP L.
A container body decorator comprising: a controller having a software routine stored on a memory; a plurality of ink-jet printing heads in communication with the controller; a segmented image transfer blanket having an endless circumferential configuration comprising a plurality of print surfaces each separated by a gap in the segmented image transfer blanket; a printing site; and a container body handling module, wherein the container body handling module comprises a plurality of impression rolls movable relative to the printing site, wherein each impression roll is configured to fit within an interior of each container body in a plurality of generally identical unadorned container bodies to be decorated by the container body decorator, wherein each impression roll in the plurality of impression rolls transports one container body in the plurality of container bodies to the printing site, wherein each container body in the plurality of container bodies contacts a printing surface of the segmented image transfer blanket at the printing site without subsequently contacting any other printing surfaces in the plurality of printing surfaces. a controller having a software routine stored on a memory; a plurality of ink-jet printing heads in communication with the controller; a segmented image transfer blanket having an endless circumferential configuration comprising a plurality of print surfaces each separated by a gap in the segmented image transfer blanket; a printing site; and a container body handling module, wherein the container body handling module comprises a plurality of impression rolls movable relative to the printing site, wherein each impression roll is configured to fit within an interior of each container body in a plurality of generally identical unadorned container bodies to be decorated by the container body decorator, wherein each impression roll in the plurality of impression rolls transports one container body in the plurality of container bodies to the printing site, wherein each container body in the plurality of container bodies contacts a printing surface of the segmented image transfer blanket at the printing site without subsequently contacting any other printing surfaces in the plurality of printing surfaces.
A crosslinkable pressure-sensitive adhesive, comprising: at least one first polymer which is the reaction product of a first ethylenically unsaturated monomer selected from the group consisting of an alkyl ester of acrylic acid, an alkyl ester of methacrylic acid, an ester of a carboxylic acid and an unsaturated alcohol and mixtures thereof; an optional second ethylenically unsaturated monomer selected from the group consisting of an olefin monomer, a vinylaromatic monomer and mixtures thereof; and from 1% to 10% by weight of the at least one polymer of a polar monomer selected from the group consisting of a monomer of formula I and a mixture of the monomer of formula I and a monomer of formula II: H 2 C=CH-L 1 -OH I H 2 C=CH-L 2 -CO 2 H II wherein L 1 and L 2 are independently selected from the group consisting of a direct bond and an alkylene group of formula -(CH 2) m -[X-(CH 2) n] o -; m and n are independently selected from the group consisting of 0, 1, 2, 3, and 4; o is from 0 to 10; and X is absent or is a group selected from the group consisting of -CHR-, -O-, -S-, -CO 2 -, -CO-, -CONH-, -NHCO-, and -NHCO 2 -, where R is lower alkyl; a first multifunctional crosslinking agent having at least two epoxide rings or at least one epoxide ring and at least one aziridine ring; and a second multifunctional crosslinking agent having at least two isocyanate groups. at least one first polymer which is the reaction product of a first ethylenically unsaturated monomer selected from the group consisting of an alkyl ester of acrylic acid, an alkyl ester of methacrylic acid, an ester of a carboxylic acid and an unsaturated alcohol and mixtures thereof; an optional second ethylenically unsaturated monomer selected from the group consisting of an olefin monomer, a vinylaromatic monomer and mixtures thereof; and from 1% to 10% by weight of the at least one polymer of a polar monomer selected from the group consisting of a monomer of formula I and a mixture of the monomer of formula I and a monomer of formula II: H 2 C=CH-L 1 -OH I H 2 C=CH-L 2 -CO 2 H II wherein L 1 and L 2 are independently selected from the group consisting of a direct bond and an alkylene group of formula -(CH 2) m -[X-(CH 2) n] o -; m and n are independently selected from the group consisting of 0, 1, 2, 3, and 4; o is from 0 to 10; and X is absent or is a group selected from the group consisting of -CHR-, -O-, -S-, -CO 2 -, -CO-, -CONH-, -NHCO-, and -NHCO 2 -, where R is lower alkyl; wherein L 1 and L 2 are independently selected from the group consisting of a direct bond and an alkylene group of formula -(CH 2) m -[X-(CH 2) n] o -; m and n are independently selected from the group consisting of 0, 1, 2, 3, and 4; o is from 0 to 10; and X is absent or is a group selected from the group consisting of -CHR-, -O-, -S-, -CO 2 -, -CO-, -CONH-, -NHCO-, and -NHCO 2 -, where R is lower alkyl; a first multifunctional crosslinking agent having at least two epoxide rings or at least one epoxide ring and at least one aziridine ring; and a second multifunctional crosslinking agent having at least two isocyanate groups.
An epoxy resin, comprising an epoxy compound, the epoxy compound having two aromatic rings that form a divalent biphenyl structure and mesogenic structures that are bonded to each of the two aromatic rings, and at least one of bonding sites of the aromatic ring to the mesogenic structure being at an ortho position or a meta position with respect to a carbon atom that bonds the aromatic rings.
An earphone comprising: a housing; an insertion portion for inserting into the external auditory meatus of a user; a dynamic driver unit provided in the housing; a sound conduit having a length of approximately 10 mm or more, the sound conduit being configured to transmit sound output from the dynamic driver unit to a first sound guide hole in the insertion portion for outputting sound to the external meatus; and a balanced armature driver unit coupled to a second sound guide hole in the insertion portion for outputting sound to the external meatus; wherein part of the sound output from the second guide hole enters the first guide hole and is led outside the housing through the dynamic driver unit to attenuate low frequencies of the sound output from the balanced armature driver unit. a housing; an insertion portion for inserting into the external auditory meatus of a user; a dynamic driver unit provided in the housing; a sound conduit having a length of approximately 10 mm or more, the sound conduit being configured to transmit sound output from the dynamic driver unit to a first sound guide hole in the insertion portion for outputting sound to the external meatus; and a balanced armature driver unit coupled to a second sound guide hole in the insertion portion for outputting sound to the external meatus; wherein part of the sound output from the second guide hole enters the first guide hole and is led outside the housing through the dynamic driver unit to attenuate low frequencies of the sound output from the balanced armature driver unit.